BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6943601)

  • 21. Upregulation of the immune system in primary hypercholesterolaemia: effect of atorvastatin therapy.
    Sampietro T; Bigazzi F; Rossi G; Dal Pino B; Puntoni MR; Sbrana F; Chella E; Bionda A
    J Intern Med; 2005 Jun; 257(6):523-30. PubMed ID: 15910556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [CH50, C3 and C4 in the serum and synovial fluid of rheumatoid arthritis patients].
    Sheĭtanov I; Nikolov K; Petrova P
    Vutr Boles; 1987; 26(4):66-70. PubMed ID: 3499707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome.
    Ramos-Casals M; Brito-Zerón P; Yagüe J; Akasbi M; Bautista R; Ruano M; Claver G; Gil V; Font J
    Rheumatology (Oxford); 2005 Jan; 44(1):89-94. PubMed ID: 15381790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immune complex and complement levels in spontaneous abortions and normal pregnancy].
    Saitoh S; Nakanishi A; Ichijo M
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Nov; 35(11):1981-90. PubMed ID: 6607297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increase of serum complement levels in cancer patients with progressing tumors.
    Verhaegen H; De Cock W; De Cree J; Verbruggen F
    Cancer; 1976 Oct; 38(4):1608-13. PubMed ID: 991081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products.
    Wouters D; Voskuyl AE; Molenaar ET; Dijkmans BA; Hack CE
    Arthritis Rheum; 2006 Apr; 54(4):1143-50. PubMed ID: 16572449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of normal ranges for serum C3 and C4 levels in an adult Zimbabwean population.
    Gomo R; Sibanda EN
    Cent Afr J Med; 2002; 48(11-12):137-41. PubMed ID: 14562600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute hepatitis: significance of changes in complement components.
    Charlesworth JA; Lawrence S; Worsdall PA; Roy LP; Boughton CR
    Clin Exp Immunol; 1977 Jun; 28(3):496-501. PubMed ID: 891025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total hemolytic complement (CH50) and its fractions C3 and C4 in the sera of patients with localized juvenile periodontitis.
    Anil S; Beena VT; Remani P; Mysore J; Vijayakumar T
    Ann Dent; 1993; 52(1):18-20. PubMed ID: 8323245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
    Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
    Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of patients with premalignant and malignant lesions of the oral cavity.
    Rajendran R; Remani P; Vijayakumar T; Vasudevan DM
    Ann Dent; 1990; 49(1):36-8, 51. PubMed ID: 2346298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes of serum complement and of circulating immune complexes in patients with multiple sclerosis.
    Cojocaru M; Serbănescu A; Cojocaru IM
    Rom J Intern Med; 1993; 31(2):131-7. PubMed ID: 8268831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro synthesis of some complement components (C1q, C3 and C4) by lymphoid tissues and circulating leucocytes in man.
    Lai A Fat RF; van Furth R
    Immunology; 1975 Feb; 28(2):359-68. PubMed ID: 804438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement activation in fetuses: assessment by the levels of complement components and split products in cord blood.
    Miyano A; Nakayama M; Fujita T; Kitajima H; Imai S; Shimizu A
    Diagn Clin Immunol; 1987; 5(2):86-90. PubMed ID: 3497734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunology of chronic generalized periodontitis. 2. Estimation of total hemolytic complement (CH 50) and its fractions C3 and C4.
    Anil S; Beena VT; Remani P; Haseenabeevi M; Vijayakumar T
    Indian J Dent Res; 1991; 2(3-4):35-9. PubMed ID: 1821159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating immune complexes and complement levels in hemophilic children.
    Verroust F; Adam C; Kourilsky O; Allain JP; Verroust P
    J Clin Lab Immunol; 1981 Sep; 6(2):127-30. PubMed ID: 6912882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Modification of C3 and C4 levels after the administration of conjugated estrogens plus medroxiprogesterone or raloxifene in postmenopausal women].
    Carranza Lira S; MacGregor Gooch AL; Olivares A; González Legorreta SL; Saldívar N; Martínez Chéquer JC
    Ginecol Obstet Mex; 2005 Oct; 73(10):521-4. PubMed ID: 16583831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum complement levels in patients with cancer of the uterine cervix before and after radiation therapy.
    Pulay AT; Füst G; Csömör A
    Neoplasma; 1980; 27(2):211-6. PubMed ID: 7393359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes of serum complement concentrations in tumour patients prior and after radiotherapy.
    Beyer-Enke SA; Strauss LG; Georgi M
    Strahlenther Onkol; 1986 Jul; 162(7):441-7. PubMed ID: 3488595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences between plasma and serum complement in patients with chronic liver disease.
    Inai S; Kitamura H; Fujita T; Kojima J; Nagaki K
    Clin Exp Immunol; 1976 Sep; 25(3):403-9. PubMed ID: 963909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.